Complete Filing Data
Rein Therapeutics, Inc. reported Net Income Loss of -$49.87 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Rein Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$49.9M | -$62.9M | -$15.7M | -$27.3M | -$26.2M | -$27.3M | -$29.4M | -$31.5M | -$22.6M | -$18.1M | -$12.9M |
| Revenue * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$15.0K | $45.0K | $48.0K | -$35.0K | -$11.0K | -$9.0K | $12.0K | $28.0K | -$33.0K | -$4.0K | |
| Research And Development Expense | $11.0M | $14.2M | $4.0M | $18.0M | $17.0M | $11.2M | $17.7M | $18.4M | $14.2M | $10.3M | $7.8M |
| Operating Income Loss | -$50.6M | -$65.1M | -$16.3M | -$27.6M | -$26.6M | -$20.5M | -$30.0M | -$31.9M | -$23.0M | -$18.2M | -$12.9M |
| Operating Expenses | $50.6M | $65.1M | $16.3M | $27.6M | $26.6M | $20.5M | $30.0M | $31.9M | $23.0M | $18.2M | $12.9M |
| General And Administrative Expense | $10.9M | $13.9M | $11.4M | $9.7M | $9.6M | $9.3M | $12.3M | $13.5M | $8.8M | $7.9M | $5.1M |
| Comprehensive Income Net Of Tax | -$49.9M | -$62.8M | -$15.7M | -$27.4M | -$26.2M | -$21.2M | -$29.4M | -$31.5M | -$22.6M | -$18.1M | -$12.9M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$44.0K | $45.0K | -$15.0K | -$35.0K | -$11.0K | -$9.0K | $12.0K | $28.0K | -$33.0K | -$4.0K | |
| Interest Income Expense Nonoperating Net | $587.0K | $355.0K | $404.0K | $46.0K | $13.0K | ||||||
| Other Nonoperating Income Expense | $48.0K | $685.0K | $544.0K | $318.0K | $441.0K | -$661.0K | $587.0K | ||||
| Net Income Loss Available To Common Stockholders Basic | -$31.5M | -$22.6M | -$18.2M | -$12.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$5.6M | -$6.8M | -$5.5M | -$5.8M | -$8.9M | -$7.1M | -$1.8M | -$1.8M | -$4.8M | -$6.4M | -$8.0M | -$8.4M | -$6.7M | -$5.7M | -$7.0M | -$4.9M | -$5.0M | -$4.4M | -$6.7M | -$7.2M | -$7.7M | -$7.2M | -$7.2M | -$7.0M | -$7.4M | -$9.5M | -$7.6M | -$6.9M | -$6.3M | -$4.9M | -$4.6M | -$4.4M | -$4.2M | -$5.5M | -$3.9M |
| Revenue * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $12.0K | -$45.0K | -$4.0K | $41.0K | $0.00 | $2.0K | $8.0K | $38.0K | $3.0K | -$26.0K | -$62.0K | -$5.0K | $13.0K | -$5.0K | -$1.0K | $1.0K | -$1.0K | -$8.0K | -$10.0K | -$7.0K | $24.0K | $5.0K | -$2.0K | $9.0K | $38.0K | -$17.0K | -$27.0K | -$6.0K | $1.0K | -$3.0K | -$5.0K | $7.0K | ||
| Research And Development Expense | $1.7M | $4.3M | $3.1M | $3.7M | $3.7M | $3.5M | $22.0K | $187.0K | $1.8M | $4.2M | $5.4M | $5.9M | $4.3M | $3.9M | $4.3M | $1.9M | $2.7M | $2.5M | $4.1M | $4.7M | $4.5M | $4.3M | $4.2M | $4.0M | $4.3M | $5.3M | $4.8M | $4.3M | $3.8M | $3.2M | $2.9M | $3.1M | $2.6M | $2.1M | $2.5M |
| Operating Income Loss | -$5.5M | -$6.9M | -$5.6M | -$6.1M | -$9.0M | -$7.2M | -$2.0M | -$2.0M | -$5.0M | -$6.5M | -$8.0M | -$8.4M | -$6.8M | -$6.0M | -$7.0M | -$4.2M | -$5.0M | -$4.4M | -$6.9M | -$7.3M | -$7.9M | -$7.4M | -$7.3M | -$7.0M | -$7.5M | -$9.7M | -$7.8M | -$7.0M | -$6.4M | -$5.0M | -$4.6M | -$4.4M | -$4.2M | -$5.6M | -$3.9M |
| Operating Expenses | $5.5M | $6.9M | $5.6M | $6.1M | $9.0M | $7.2M | $2.0M | $2.0M | $5.0M | $6.5M | $8.0M | $8.4M | $6.8M | $6.0M | $7.0M | $4.2M | $5.0M | $4.4M | $6.9M | $7.3M | $7.9M | $7.4M | $7.3M | $7.0M | $7.5M | $9.7M | $7.8M | $7.0M | $6.4M | $5.0M | $4.6M | $4.4M | $4.2M | $5.6M | $3.9M |
| General And Administrative Expense | $3.8M | $2.6M | $2.6M | $2.3M | $5.3M | $3.7M | $2.0M | $1.9M | $2.2M | $2.2M | $2.6M | $2.5M | $2.5M | $2.2M | $2.7M | $2.3M | $2.3M | $1.9M | $2.8M | $2.6M | $3.4M | $3.1M | $3.1M | $3.0M | $3.2M | $4.3M | $2.9M | $2.7M | $2.6M | $1.8M | $1.6M | $1.4M | $1.6M | $3.5M | $1.4M |
| Comprehensive Income Net Of Tax | -$5.6M | -$6.8M | -$5.5M | -$5.9M | -$8.9M | -$7.1M | -$1.8M | -$1.8M | -$4.7M | -$6.4M | -$8.0M | -$8.5M | -$6.7M | -$5.7M | -$7.0M | -$4.9M | -$5.0M | -$4.4M | -$6.8M | -$7.2M | -$7.8M | -$7.1M | -$7.2M | -$7.0M | -$7.4M | -$9.5M | -$7.6M | -$6.9M | -$6.3M | -$4.9M | -$4.6M | -$4.4M | -$4.2M | -$5.5M | -$3.9M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $0.00 | -$12.0K | -$14.0K | -$4.0K | $41.0K | $0.00 | $2.0K | $8.0K | $38.0K | $3.0K | -$26.0K | -$62.0K | -$5.0K | $13.0K | -$5.0K | -$1.0K | $1.0K | -$1.0K | -$8.0K | -$10.0K | -$7.0K | $24.0K | $5.0K | -$2.0K | $9.0K | $38.0K | -$17.0K | -$27.0K | -$6.0K | $1.0K | -$3.0K | -$5.0K | $7.0K | ||
| Interest Income Expense Nonoperating Net | $155.0K | $112.0K | $55.0K | $110.0K | $49.0K | $21.0K | $21.0K | $19.0K | $14.0K | $5.0K | $10.0K | $62.0K | $112.0K | $166.0K | $207.0K | $100.0K | -$52.0K | $64.0K | $168.0K | $175.0K | $176.0K | $167.0K | $29.0K | $32.0K | $6.0K | $10.0K | $16.0K | $14.0K | |||||||
| Other Nonoperating Income Expense | -$89.0K | $49.0K | $108.0K | $224.0K | $97.0K | $92.0K | $156.0K | $205.0K | $232.0K | $4.0K | $0.00 | -$22.0K | $66.0K | $304.0K | $0.00 | -$738.0K | $5.0K | $10.0K | $62.0K | $112.0K | $166.0K | $208.0K | $101.0K | ||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$7.4M | -$9.5M | -$7.6M | -$6.9M | -$6.3M | -$4.9M | -$4.6M | -$4.5M | -$4.2M | -$5.6M | -$3.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $16.9M | $54.4M | $98.3M | $18.6M | $12.2M | $16.0M | $19.6M | $47.8M | -$111.8M | -$94.3M | -$82.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $5.2M | $3.6M | $7.6M | $5.9M | $11.2M | $12.0M | $20.8M | |||||
| Cash And Cash Equivalents At Carrying Value | $3.2M | $12.9M | $17.3M | $5.2M | $3.6M | $7.0M | $5.3M | $10.6M | $11.9M | $20.7M | $3.8M | $6.2M |
| Retained Earnings Accumulated Deficit | -$401.3M | -$351.4M | -$288.5M | -$272.8M | -$245.5M | -$219.3M | -$198.1M | -$168.5M | -$136.9M | -$114.3M | ||
| Property Plant And Equipment Net | $0.00 | $1.0K | $19.0K | $70.0K | $128.0K | $15.0K | $295.0K | $7.3M | $154.0K | $107.0K | ||
| Prepaid Expense And Other Assets Current | $1.1M | $792.0K | $882.0K | $606.0K | $2.2M | $1.9M | $1.2M | $1.1M | $1.0M | $333.0K | ||
| Liabilities Current | $6.2M | $5.7M | $4.4M | $3.4M | $4.5M | $4.0M | $5.8M | $5.4M | $4.9M | $4.1M | ||
| Liabilities And Stockholders Equity | $24.2M | $62.2M | $106.0M | $22.0M | $48.5M | $16.3M | $26.5M | $30.3M | $52.7M | $22.0M | ||
| Liabilities | $7.2M | $7.8M | $7.7M | $3.4M | $4.6M | $4.2M | $10.4M | $10.7M | $4.9M | $4.1M | ||
| Assets Current | $4.3M | $13.7M | $18.3M | $21.9M | $48.2M | $16.3M | $19.6M | $21.8M | $51.8M | $21.1M | ||
| Assets | $24.2M | $62.2M | $106.0M | $22.0M | $48.5M | $16.3M | $26.5M | $30.3M | $52.7M | $22.0M | ||
| Additional Paid In Capital Common Stock | $373.1M | $360.7M | $295.4M | $291.4M | $289.3M | $231.4M | $214.1M | $188.1M | $184.8M | $2.5M | ||
| Accrued Liabilities And Other Liabilities | $2.2M | $4.8M | $3.1M | $1.6M | $3.2M | $2.2M | $3.9M | $3.6M | $3.3M | $2.1M | ||
| Accounts Payable Current | $4.0M | $911.0K | $1.2M | $1.7M | $1.2M | $1.6M | $1.5M | $1.7M | $1.6M | $2.0M | ||
| Common Stock Value | $113.0K | $108.0K | $91.0K | $91.0K | $91.0K | $44.0K | $28.0K | $15.0K | $15.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$9.7M | -$4.5M | $12.1M | $1.6M | -$4.0M | $1.7M | -$5.3M | -$723.0K | -$8.9M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$62.0K | -$18.0K | -$63.0K | -$48.0K | -$13.0K | -$2.0K | $7.0K | -$5.0K | -$33.0K | |||
| Restricted Cash Current | $25.0K | $25.0K | $25.0K | $593.0K | $25.0K | $25.0K | $88.0K | $25.0K | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | -$32.0K | $208.0K | -$240.0K | $9.0K | $231.0K | $253.0K | $152.0K | ||||
| Other Assets Noncurrent | $2.0K | $2.0K | $2.2M | $24.0K | $24.0K | $679.0K | $694.0K | $778.0K | ||||
| Available For Sale Securities Debt Securities Current | $16.0M | $42.3M | $6.8M | $13.0M | $10.1M | $38.9M | $0.00 | |||||
| Operating Lease Liability Current | $48.0K | $33.0K | $93.0K | $446.0K | ||||||||
| Operating Lease Right Of Use Asset | $40.0K | $152.0K | $6.1M | |||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$6.0K | $66.0K | $86.0K | -$5.0K | -$12.0K | ||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $41.0K | $75.0K | $71.0K | |||||||||
| Restricted Cash | $0.00 | $25.0K | $25.0K | $25.0K | $593.0K | $593.0K | $593.0K | |||||
| Restricted Cash Noncurrent | $568.0K | $568.0K | $63.0K | |||||||||
| Stockholder Equity Including Convertible Preferred Stock | $43.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $46.2M | $48.0M | $49.9M | $95.2M | $101.0M | $91.3M | $11.2M | $12.8M | $14.3M | $22.7M | $28.6M | $36.1M | $43.9M | $50.1M | $56.1M | $61.4M | $12.5M | $16.7M | $9.8M | $22.8M | $30.0M | $12.8M | $26.0M | $32.9M | $41.0M | $54.0M | -$120.8M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $4.0M | $5.7M | $7.4M | $12.9M | $17.7M | $21.9M | $12.1M | $17.3M | $12.1M | $13.2M | $7.8M | $4.9M | $7.7M | $7.5M | $7.6M | $10.8M | $19.3M | $8.4M | $17.7M | $11.3M | $7.5M | $10.8M | $11.9M | $8.3M | $12.6M | $7.4M | $13.4M | $9.4M | |||||||
| Cash And Cash Equivalents At Carrying Value | $4.0M | $5.7M | $7.4M | $17.7M | $21.9M | $12.0M | $12.1M | $13.2M | $7.8M | $4.8M | $7.6M | $7.4M | $7.6M | $10.7M | $19.3M | $7.9M | $17.1M | $10.7M | $6.9M | $10.2M | $11.3M | $7.7M | $12.0M | $6.8M | $13.4M | $9.4M | $4.5M | $3.9M | |||||||
| Retained Earnings Accumulated Deficit | -$369.3M | -$363.7M | -$356.9M | -$310.4M | -$304.6M | -$295.6M | -$281.2M | -$279.4M | -$277.6M | -$268.2M | -$261.9M | -$253.9M | -$238.7M | -$232.0M | -$226.3M | -$214.3M | -$209.3M | -$204.9M | -$190.9M | -$183.2M | -$176.0M | -$161.5M | -$154.0M | -$144.5M | -$130.1M | -$123.8M | |||||||||
| Property Plant And Equipment Net | $0.00 | $1.0K | $1.0K | $1.0K | $2.0K | $6.0K | $29.0K | $39.0K | $52.0K | $84.0K | $98.0K | $113.0K | $144.0K | $153.0K | $98.0K | $147.0K | $164.0K | $225.0K | $361.0K | $379.0K | $398.0K | $6.8M | $4.1M | $134.0K | $111.0K | $109.0K | |||||||||
| Prepaid Expense And Other Assets Current | $1.1M | $880.0K | $903.0K | $1.0M | $1.2M | $697.0K | $699.0K | $261.0K | $359.0K | $1.6M | $1.1M | $1.9M | $2.2M | $648.0K | $948.0K | $1.8M | $765.0K | $967.0K | $1.9M | $1.0M | $1.1M | $2.1M | $1.4M | $1.1M | $1.2M | $561.0K | |||||||||
| Liabilities Current | $5.7M | $7.7M | $6.0M | $5.7M | $4.9M | $4.5M | $1.6M | $1.2M | $2.9M | $4.5M | $5.2M | $4.1M | $4.6M | $4.3M | $3.1M | $5.2M | $4.9M | $6.1M | $6.4M | $5.4M | $4.6M | $7.1M | $6.4M | $4.9M | $5.0M | $5.5M | |||||||||
| Liabilities And Stockholders Equity | $53.7M | $57.5M | $57.6M | $104.2M | $109.4M | $99.2M | $12.8M | $14.0M | $17.2M | $27.2M | $33.8M | $40.3M | $54.8M | $60.5M | $64.7M | $22.2M | $26.1M | $20.4M | $34.0M | $40.2M | $22.4M | $38.1M | $42.6M | $45.8M | $59.0M | $15.1M | |||||||||
| Liabilities | $7.5M | $9.5M | $7.7M | $9.0M | $8.4M | $7.9M | $1.6M | $1.2M | $2.9M | $4.5M | $5.2M | $4.1M | $4.7M | $4.4M | $3.3M | $9.8M | $9.5M | $10.6M | $11.1M | $10.2M | $9.6M | $12.1M | $9.7M | $4.9M | $5.0M | $5.5M | |||||||||
| Assets Current | $5.2M | $6.6M | $8.3M | $18.7M | $23.2M | $12.8M | $12.8M | $14.0M | $17.1M | $27.1M | $33.6M | $40.0M | $54.4M | $60.2M | $64.3M | $16.0M | $19.7M | $13.7M | $26.5M | $32.6M | $14.4M | $30.1M | $37.2M | $44.4M | $58.1M | $12.0M | |||||||||
| Assets | $53.7M | $57.5M | $57.6M | $104.2M | $109.4M | $99.2M | $12.8M | $14.0M | $17.2M | $27.2M | $33.8M | $40.3M | $54.8M | $60.5M | $64.7M | $22.2M | $26.1M | $20.4M | $34.0M | $40.2M | $22.4M | $38.1M | $42.6M | $45.8M | $59.0M | $15.1M | |||||||||
| Additional Paid In Capital Common Stock | $370.4M | $366.6M | $361.7M | $360.6M | $360.5M | $340.3M | $292.3M | $292.1M | $291.8M | $290.9M | $290.5M | $290.0M | $288.7M | $288.0M | $287.6M | $226.7M | $225.9M | $214.6M | $213.7M | $213.1M | $188.8M | $187.5M | $186.9M | $185.5M | $184.1M | $3.0M | |||||||||
| Accrued Liabilities And Other Liabilities | $1.6M | $1.7M | $4.8M | $4.6M | $4.2M | $2.4M | $1.1M | $1.1M | $2.4M | $3.5M | $3.3M | $3.0M | $3.4M | $3.2M | $2.1M | $3.7M | $3.3M | $4.6M | $3.7M | $3.3M | $3.4M | $4.1M | $4.8M | $3.1M | $3.4M | $3.3M | |||||||||
| Accounts Payable Current | $4.1M | $6.0M | $1.1M | $1.1M | $782.0K | $2.2M | $484.0K | $136.0K | $458.0K | $945.0K | $1.7M | $1.0M | $1.0M | $1.0M | $560.0K | $1.0M | $993.0K | $1.1M | $2.3M | $1.7M | $858.0K | $3.0M | $1.6M | $1.8M | $1.7M | $2.2M | |||||||||
| Common Stock Value | $111.0K | $109.0K | $108.0K | $108.0K | $107.0K | $103.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $40.0K | $39.0K | $28.0K | $28.0K | $28.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $0.00 | $0.00 | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$5.4M | -$5.3M | $2.6M | $3.8M | $11.7M | $5.4M | $637.0K | -$4.5M | -$12.7M | ||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$44.0K | -$44.0K | -$32.0K | -$26.0K | -$22.0K | -$63.0K | -$2.0K | -$10.0K | -$98.0K | -$101.0K | -$75.0K | $1.0K | $6.0K | -$7.0K | -$1.0K | -$2.0K | -$1.0K | $17.0K | $24.0K | -$3.0K | -$12.0K | -$50.0K | -$6.0K | ||||||||||||
| Restricted Cash Current | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $88.0K | $88.0K | $88.0K | ||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $103.0K | $3.0K | -$62.0K | $30.0K | $34.0K | $44.0K | ||||||||||||||||||||||||||||
| Other Assets Noncurrent | $2.0K | $2.3M | $766.0K | $2.0K | $709.0K | $892.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $21.0K | $302.0K | $302.0K | $501.0K | $680.0K | $680.0K | $683.0K | $808.0K | $782.0K | |||||||||||||||
| Available For Sale Securities Debt Securities Current | $499.0K | $8.9M | $20.6M | $24.8M | $30.6M | $44.6M | $48.7M | $44.1M | $6.3M | $1.8M | $2.0M | $17.7M | $21.4M | $2.0M | $20.2M | $23.8M | $36.5M | $43.4M | $1.9M | ||||||||||||||||
| Operating Lease Liability Current | $67.0K | $100.0K | $131.0K | $93.0K | $93.0K | $93.0K | $512.0K | $490.0K | $468.0K | $426.0K | $406.0K | $387.0K | |||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $70.0K | $98.0K | $125.0K | $177.0K | $202.0K | $228.0K | $5.6M | $5.7M | $5.9M | $6.2M | $6.4M | $6.5M | |||||||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$16.0K | $0.00 | $66.0K | |||||||||||||||||||||||||||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $21.0K | $20.0K | $19.0K | $19.0K | $19.0K | $18.0K | |||||||||||||||||||||||||||||
| Restricted Cash | $0.00 | $0.00 | $0.00 | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | ||||||||||||||||||||||||||
| Restricted Cash Noncurrent | $568.0K | $568.0K | $568.0K | $568.0K | $568.0K | $568.0K | $568.0K | $568.0K | $568.0K | ||||||||||||||||||||||||||
| Stockholder Equity Including Convertible Preferred Stock | $95.2M | $101.0M | $91.3M | $98.3M | $11.2M | $12.8M | $14.3M | $18.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $9.8M | $17.8M | $15.8M | $55.7M | $15.8M | $24.0M | $2.5M | $50.6M | $32.0M | -$1.4M | |
| Investing Cash Flow * | $0.00 | $16.2M | $26.5M | -$35.9M | $6.4M | -$2.8M | $24.7M | -$38.9M | -$25.0K | $10.6M | |
| Operating Cash Flow * | -$19.4M | -$22.3M | -$19.8M | -$24.9M | -$23.8M | -$20.5M | -$26.5M | -$27.9M | -$20.5M | -$15.0M | -$11.7M |
| Share Based Compensation | $2.2M | $1.1M | $1.2M | $2.1M | $2.3M | $1.9M | $2.1M | $3.3M | $1.7M | $688.0K | $626.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $319.0K | -$134.0K | -$51.0K | -$1.6M | $291.0K | $682.0K | $206.0K | $117.0K | $764.0K | $75.0K | $109.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.6M | $1.7M | -$382.0K | -$1.6M | $1.0M | -$1.7M | $385.0K | $359.0K | $1.2M | $333.0K | $584.0K |
| Increase Decrease In Accounts Payable | $3.1M | -$279.0K | -$5.0M | $510.0K | -$386.0K | $116.0K | -$277.0K | $130.0K | -$241.0K | $1.2M | -$237.0K |
| Depreciation Depletion And Amortization | $1.0K | $63.0K | $119.0K | $169.0K | $121.0K | $163.0K | $155.0K | $218.0K | $129.0K | $232.0K | $325.0K |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $0.00 | $16.3M | $48.3M | $37.8M | $16.2M | $24.6M | $60.3M | $32.3M | $12.6M | $12.4M | |
| Increase Decrease In Operating Lease Liabilities | $0.00 | -$48.0K | -$65.0K | -$129.0K | -$66.0K | -$5.0M | -$370.0K | ||||
| Proceeds From Stock Options Exercised | $4.0K | $143.0K | $0.00 | $74.0K | $165.0K | $42.0K | $111.0K | $23.0K | $52.0K | ||
| Payments To Acquire Available For Sale Securities Debt | $21.9M | $73.6M | $10.0M | $27.2M | $31.2M | $71.1M | $12.6M | $2.4M | |||
| Increase Decrease In Other Operating Assets | $0.00 | -$2.2M | $3.0K | $24.0K | -$6.1M | -$1.3M | -$15.0K | ||||
| Payments To Acquire Property Plant And Equipment | $157.0K | $5.0K | $151.0K | $4.4M | $142.0K | $94.0K | |||||
| Payments Of Stock Issuance Costs | $893.0K | $893.0K | $39.0K | $2.3M | $180.0K | $1.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $738.0K | $0.00 | $55.6M | $0.00 | $165.0K | $16.0K | $569.0K | |||||
| Investing Cash Flow * | $0.00 | $7.3M | $11.6M | -$37.5M | $11.1M | $8.0M | $2.4M | -$7.3M | ||||
| Operating Cash Flow * | -$6.2M | -$5.3M | -$4.7M | -$7.8M | -$6.5M | -$5.7M | -$7.5M | -$6.9M | -$6.0M | |||
| Share Based Compensation | $264.0K | $150.0K | $391.0K | $689.0K | $631.0K | $505.0K | $563.0K | $767.0K | $197.0K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $125.0K | -$185.0K | -$247.0K | -$326.0K | -$981.0K | -$280.0K | $50.0K | $86.0K | $330.0K | |||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$10.0K | -$771.0K | $795.0K | -$213.0K | -$105.0K | $619.0K | -$374.0K | -$231.0K | -$444.0K | |||
| Increase Decrease In Accounts Payable | $238.0K | $966.0K | -$1.3M | -$187.0K | -$1.0M | -$365.0K | -$872.0K | $196.0K | -$829.0K | |||
| Depreciation Depletion And Amortization | $0.00 | $59.0K | $43.0K | $41.0K | $2.0K | $70.0K | $31.0K | $46.0K | $22.0K | |||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $0.00 | $7.3M | $16.4M | $3.8M | $11.0M | $8.1M | $10.0M | |||||
| Increase Decrease In Operating Lease Liabilities | $0.00 | -$48.0K | -$33.0K | -$31.0K | -$12.0K | -$104.0K | -$85.0K | |||||
| Proceeds From Stock Options Exercised | $1.0K | $0.00 | $165.0K | $16.0K | $75.0K | |||||||
| Payments To Acquire Available For Sale Securities Debt | $4.7M | $41.1M | $7.5M | $7.3M | ||||||||
| Increase Decrease In Other Operating Assets | $764.0K | -$1.3M | -$24.0K | $22.0K | -$167.0K | -$533.0K | ||||||
| Payments To Acquire Property Plant And Equipment | $85.0K | $127.0K | $7.0K | $38.0K | ||||||||
| Payments Of Stock Issuance Costs | $159.0K | $1.2M | $28.0K | $37.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.96 | -$3.51 | -$3.42 | -$6.02 | -$5.89 | -$0.61 | -$1.20 | -$2.14 | -$3.04 | -$42.35 | -$32.31 | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 45.0M | 45.0M | 15.0M | 150.0M | 150.0M | 150.0M | 143.5M | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 88.8M | 34.9M | 24.5M | 14.7M | 7.4M | 429.7K | 400.7K | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 27.6M | 21.7M | 4.9M | 4.5M | 4.5M | 43.8M | 27.8M | 14.7M | 14.7M | 432.4K | ||
| Common Stock Shares Issued | 27.6M | 21.7M | 4.9M | 4.5M | 4.5M | 43.8M | 27.8M | 14.7M | 14.7M | 432.4K | ||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 25.4M | 17.9M | 4.6M | 4.5M | 4.4M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 25.4M | 17.9M | 4.6M | 4.5M | 4.4M | |||||||
| Earnings Per Share Basic | $-1.96 | $-3.51 | $-3.42 | $-6.02 | $-5.89 | |||||||
| Temporary Equity Shares Outstanding | 12.2K | 12.2K | 24.6K | 0.00 | 0.00 | 0.00 | 105.6M | 82.0M | 82.0M | |||
| Temporary Equity Shares Issued | 24.6K | 24.6K | 24.6K | 0.00 | 0.00 | 105.6M | ||||||
| Temporary Equity Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 | 151.6M | ||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.21 | -$0.28 | -$0.25 | -$0.27 | -$0.45 | -$0.86 | -$0.40 | -$0.39 | -$1.05 | -$1.40 | -$1.76 | -$1.86 | -$0.07 | -$0.06 | -$0.08 | -$0.12 | -$0.13 | -$0.14 | -$0.24 | -$0.26 | -$0.28 | -$0.26 | -$0.49 | -$0.48 | -$0.50 | -$0.64 | -$0.52 | -$0.47 | -$0.45 | -$10.98 | -$10.58 | -$10.31 | -$9.84 | -$12.95 | -$9.25 | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 45.0M | 45.0M | 45.0M | 300.0M | 300.0M | 300.0M | 300.0M | 15.0M | 150.0M | 7.5M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 90.7M | 90.5M | 90.5M | 83.4M | 41.0M | 39.3M | 31.2M | 27.8M | 27.8M | 27.8M | 27.5M | 14.8M | 14.7M | 14.7M | 14.7M | 14.7M | 14.7M | 13.9M | 450.5K | 432.7K | 432.4K | 430.9K | 428.9K | 426.5K | ||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Common Stock Shares Outstanding | 25.1M | 23.0M | 22.0M | 21.7M | 21.6M | 16.8M | 4.5M | 4.5M | 4.5M | 90.8M | 90.8M | 90.8M | 90.6M | 90.5M | 90.2M | 39.9M | 39.3M | 27.8M | 27.8M | 26.7M | 14.9M | 14.7M | 14.7M | 14.7M | 14.7M | 450.9K | ||||||||||
| Common Stock Shares Issued | 25.1M | 23.0M | 22.0M | 21.7M | 21.6M | 16.8M | 4.5M | 4.5M | 4.5M | 90.8M | 90.8M | 90.8M | 90.6M | 90.5M | 90.2M | 39.9M | 39.3M | 27.8M | 27.8M | 26.7M | 14.9M | 14.7M | 14.7M | 14.7M | 14.7M | 450.9K | ||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 26.4M | 24.2M | 21.9M | 21.7M | 19.9M | 8.3M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 90.5M | 90.5M | ||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 26.4M | 24.2M | 21.9M | 21.7M | 19.9M | 8.3M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 90.5M | 90.5M | ||||||||||||||||||||||
| Earnings Per Share Basic | $-0.21 | $-0.28 | $-0.25 | $-0.27 | $-0.45 | $-0.86 | $-0.40 | $-0.39 | $-1.05 | $-1.40 | $-1.76 | $-1.86 | $-0.07 | $-0.06 | ||||||||||||||||||||||
| Temporary Equity Shares Outstanding | 12.2K | 12.2K | 12.2K | 12.2K | 12.2K | 12.7K | 0.00 | 106.1M | ||||||||||||||||||||||||||||
| Temporary Equity Shares Issued | 24.6K | 24.6K | 24.6K | 24.6K | 24.6K | 24.6K | 0.00 | 106.1M | ||||||||||||||||||||||||||||
| Temporary Equity Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 | 151.6M | ||||||||||||||||||||||||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.2M | $1.1M | $1.2M | $2.1M | $2.3M | $1.9M | $2.1M | $3.3M | $1.7M | $688.0K | $626.0K |
| Stock Issued During Period Value Stock Options Exercised | $4.0K | $143.0K | $75.0K | $165.0K | $42.0K | $111.0K | $23.0K | $52.0K | |||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $488.0K | $3.5M | $1.5M | $2.2M | |||||||
| Stock Issued During Period Value New Issues | $10.9M | $59.1M | $16.9M | $50.0M | |||||||
| Stock Issued During Period Shares Stock Options Exercised | 21.5K | 129.0K | 0.00 | 113.0K | 126.6K | 24.7K | 31.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.4M | $256.0K | $264.0K | $508.0K | $326.0K | $150.0K | $229.0K | $300.0K | $391.0K | $442.0K | $528.0K | $689.0K | $661.0K | $361.0K | $631.0K | $465.0K | $560.0K | $505.0K | $614.0K | $460.0K | $563.0K | $588.0K | $1.3M | $767.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.0K | $42.0K | $101.0K | $27.0K | $47.0K | $165.0K | $12.0K | $16.0K | ||||||||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $404.0K | $488.0K | $24.0K | $3.5M | $1.2M | $28.0K | $37.0K | |||||||||||||||||
| Stock Issued During Period Value New Issues | $33.0K | $738.0K | $10.9M | $59.1M | $364.0K | $11.9M | ||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 21.5K | 0.00 | 126.6K | 10.6K |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.